Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Ironwood Pharmaceuticals, Inc. (IRWD) had Return on Investments of 22.98% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$113.04M |
|
$51.29M |
|
-- |
|
$113.04M |
|
$33.73M |
|
$79.31M |
|
$-5.58M |
|
$73.73M |
|
$73.73M |
|
$51.29M |
|
$51.29M |
|
$51.29M |
|
$51.29M |
|
$79.31M |
|
$79.76M |
|
164.41M |
|
167.18M |
|
$0.31 |
|
$0.31 |
|
| Balance Sheet Financials | |
$199.20M |
|
$2.91M |
|
$85.93M |
|
$285.13M |
|
$32.85M |
|
$385.00M |
|
$414.12M |
|
$446.97M |
|
$-161.84M |
|
$-163.48M |
|
$-161.84M |
|
165.24M |
|
| Cash Flow Statement Financials | |
$63.40M |
|
$0.00M |
|
$-199.70M |
|
$215.46M |
|
$79.13M |
|
$-136.33M |
|
$6.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.06 |
|
-- |
|
-- |
|
1.73 |
|
-2.38 |
|
100.00% |
|
70.16% |
|
70.16% |
|
-- |
|
65.22% |
|
45.37% |
|
$63.40M |
|
-- |
|
-- |
|
-- |
|
0.40 |
|
-- |
|
1.00 |
|
89.75 |
|
-31.69% |
|
-31.38% |
|
17.99% |
|
|
Return on Investments |
22.98% |
$-0.98 |
|
$0.38 |
|
$0.38 |
|